Resources
News & Events
ICLE 2022 |31th March – 2st April Munich
Maik Luu will present T2EVOLVE at the ICLE in Munich (31th March- 2nd April).
DIA EUROPE 2022 | 29-31 MARCH 2022 BRUSSELS &VIRTUAL
Helene Negre has been invited to speak during the upcoming DIA Europe 2022 on March 31 in Brussels.
SFTCG Annual Meeting | 16-18 March 2022
Helene Negre will present T2EVOLVE at annual meeting SFTCG on Thursday 17th March at 11:30 am
Cell Therapy Symposium Conference
T2EVOLVE consortium presentation at The Cell Therapy Analytics Symposium.
EHA/EBMT CAR T-CELL HANDBOOK
Now freely accessible to download.
European survey related to analytical controls of engineered T-cells
After several months of hard work and collaboration, we are pleased to launch our European survey related to analytical controls of engineered T-cells! To ensure the best success, quality, and representativity of survey’s results, we count on your participation and...
Latest Tweets
Publications
- Time to evolve: predicting engineered T cell-associated toxicity with next-generation models
- Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?
- CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models
- Targeting metabolic rewiring might decrease spread of tumor cells: Mitochondrial tRNA modifications promote cancer metastasis
- CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
- CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome
Materials
Partner perspectives
5th European CAR T-cell meeting posters
